PDF(Pubmed)
Abstract：
The growing trend of STIs in recent years was altered after the outbreak of the SARS-CoV-2 pandemic.
Describe the impact of the SARS-CoV-2 pandemic on STI declarations received during the pre-pandemic to pandemic period and estimate the number of STI cases expected for the pandemic period.
Descriptive analysis of STI declarations received during the pre-pandemic (2018-2019) and pandemic (2020-2021) periods. The influence of the number of positive cases of SARS-CoV-2 with the number of positive cases of STIs during the months of the pandemic was studied using a correlation model. Using the Holt-Wilson time series model, an estimate was made of the number of STI cases expected for the pandemic period.
The global incidence rate for all STIs in 2020 decreased by 18.3% compared to 2019. Chlamydia and syphilis presented a greater reduction in their incidence from 2019 to 2020 of 22.7% and 20.9%, respectively and 9.5% and 2.5% for gonorrhea and LGV. Estimates showed that in 2020 there would have been 44.6% more STIs than those declared. The proportions according to sex, country of birth and sexual orientation changed significantly in chlamydia and gonorrhea.
The measures adopted for the prevention of SARS-CoV-2 infections were able to achieve an initial decrease in STI cases in 2020, however, this change was not maintained during 2021, which ended with higher incidences recorded to date.
Describe the impact of the SARS-CoV-2 pandemic on STI declarations received during the pre-pandemic to pandemic period and estimate the number of STI cases expected for the pandemic period.
Descriptive analysis of STI declarations received during the pre-pandemic (2018-2019) and pandemic (2020-2021) periods. The influence of the number of positive cases of SARS-CoV-2 with the number of positive cases of STIs during the months of the pandemic was studied using a correlation model. Using the Holt-Wilson time series model, an estimate was made of the number of STI cases expected for the pandemic period.
The global incidence rate for all STIs in 2020 decreased by 18.3% compared to 2019. Chlamydia and syphilis presented a greater reduction in their incidence from 2019 to 2020 of 22.7% and 20.9%, respectively and 9.5% and 2.5% for gonorrhea and LGV. Estimates showed that in 2020 there would have been 44.6% more STIs than those declared. The proportions according to sex, country of birth and sexual orientation changed significantly in chlamydia and gonorrhea.
The measures adopted for the prevention of SARS-CoV-2 infections were able to achieve an initial decrease in STI cases in 2020, however, this change was not maintained during 2021, which ended with higher incidences recorded to date.
摘要：
背景：SARS-CoV-2大流行爆发后，近年来性传播感染的增长趋势发生了变化。
目的：描述SARS-CoV-2大流行对在大流行前到大流行期间收到的STI声明的影响，并估计大流行期间预期的STI病例数。
方法：对大流行前（2018-2019年）和大流行（2020-2021年）期间收到的性传播感染声明进行描述性分析。使用相关模型研究了在大流行的几个月中，SARS-CoV-2阳性病例数与性传播感染阳性病例数的影响。利用霍尔特-威尔逊时间序列模型，对大流行期间预期的性传播感染病例数进行了估计.
结果：与2019年相比，2020年所有性传播感染的全球发病率下降了18.3％。从2019年到2020年，衣原体和梅毒的发病率下降幅度更大，分别为22.7%和20.9%，淋病和LGV分别为9.5%和2.5%。估计显示，到2020年，性传播感染将比宣布的多44.6%。根据性别的比例，衣原体和淋病的出生国和性取向发生了显着变化。
结论：为预防SARS-CoV-2感染而采取的措施能够在2020年实现性传播感染病例的初步减少，这一变化在2021年没有保持，截至目前，这一变化以更高的发病率告终。
目的：描述SARS-CoV-2大流行对在大流行前到大流行期间收到的STI声明的影响，并估计大流行期间预期的STI病例数。
方法：对大流行前（2018-2019年）和大流行（2020-2021年）期间收到的性传播感染声明进行描述性分析。使用相关模型研究了在大流行的几个月中，SARS-CoV-2阳性病例数与性传播感染阳性病例数的影响。利用霍尔特-威尔逊时间序列模型，对大流行期间预期的性传播感染病例数进行了估计.
结果：与2019年相比，2020年所有性传播感染的全球发病率下降了18.3％。从2019年到2020年，衣原体和梅毒的发病率下降幅度更大，分别为22.7%和20.9%，淋病和LGV分别为9.5%和2.5%。估计显示，到2020年，性传播感染将比宣布的多44.6%。根据性别的比例，衣原体和淋病的出生国和性取向发生了显着变化。
结论：为预防SARS-CoV-2感染而采取的措施能够在2020年实现性传播感染病例的初步减少，这一变化在2021年没有保持，截至目前，这一变化以更高的发病率告终。
